Novavax | NVAX - Trade Debtors

Stock Price
8.70
Daily Change
0.28 3.33%
Monthly
6.23%
Yearly
6.23%
Q1 Forecast
8.43

Novavax reported $94.96M in Trade Debtors for its fiscal quarter ending in September of 2024.





Trade Debtors Change Date
Adma Biologics USD 137.67M 27.94M Sep/2025
Agenus USD 354K 53K Mar/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
BioCryst Pharmaceuticals USD 79.07M 6.61M Dec/2024
Cassava Sciences USD 817K 18K Sep/2025
Geron USD 39.36M 5.38M Jun/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
MannKind USD 17.38M 9.76M Sep/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Novartis USD 8.98B 192M Sep/2025
Novavax USD 94.96M 62.81M Sep/2024
Pfizer USD 18.12B 2.02B Sep/2025
Sanofi EUR 397M 100M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025